These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 17099778)
1. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219 [TBL] [Abstract][Full Text] [Related]
3. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927 [TBL] [Abstract][Full Text] [Related]
5. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]
6. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Wu X; Eder P; Chang B; Molkentin JD Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294 [TBL] [Abstract][Full Text] [Related]
7. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. Nakayama H; Wilkin BJ; Bodi I; Molkentin JD FASEB J; 2006 Aug; 20(10):1660-70. PubMed ID: 16873889 [TBL] [Abstract][Full Text] [Related]
8. PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes. Poteser M; Schleifer H; Lichtenegger M; Schernthaner M; Stockner T; Kappe CO; Glasnov TN; Romanin C; Groschner K Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10556-61. PubMed ID: 21653882 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714 [TBL] [Abstract][Full Text] [Related]
11. TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6. Yáñez-Bisbe L; Moya M; Rodríguez-Sinovas A; Ruiz-Meana M; Inserte J; Tajes M; Batlle M; Guasch E; Mas-Stachurska A; Miró E; Rivas N; Ferreira González I; Garcia-Elias A; Benito B Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338818 [TBL] [Abstract][Full Text] [Related]
12. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847 [TBL] [Abstract][Full Text] [Related]
14. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539 [TBL] [Abstract][Full Text] [Related]
15. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465 [TBL] [Abstract][Full Text] [Related]
16. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway. Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961 [TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition. Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855 [TBL] [Abstract][Full Text] [Related]
18. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy. Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668 [TBL] [Abstract][Full Text] [Related]
19. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related]
20. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]